Back

PCSK9 deficiency results in altered insulin secretion and glucose intolerance: the role of the LDL-receptor

28 August 2018 (11:00 - 11:09)
Organised by:
Congress Presentation Part of: The basic science of diabetes and the metabolic syndrome Lipids, Metabolism ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Giuseppe Danilo Norata

University of Milan, Milan (Italy)

9 More presentations in this session

Presentation thumbnail
Myocardial perfusion reserve index in type 2 diabetes as determined by cardiac magnetic resonance imaging
Doctor M. Soerensen (Slagelse, DK)
Abstract Slides Video
Presentation thumbnail
Mitochondrial complex II activity before and after hypoxic reperfusion in low and high fat diet mice heart
Doctor S. Zhu (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Hematopoietic ABCA1 and ABCG1 regulate monocytosis, macrophage inflammation and insulin resistance in diet-induced obesity.
Associate Professor C. Tang (Seattle, US)
Abstract
Presentation thumbnail
AP-1 transcription factor JunD protects against cardiac microRNA derangement in diabetes
Doctor R. Suades (Barcelona, ES)
Abstract
Presentation thumbnail
Galectin 4 bridging the gap in cardiometabolic disease predicting diabetes, coronary events and mortality in a Swedish population cohort
Doctor J. Molvin (Malmoe, SE)
Abstract Slides Video

Access the full session

Session thumbnail
The basic science of diabetes and the metabolic syndrome

The Event

Event poster

ESC Congress 2018

28 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Association between pcsk9 levels and diabetes risk: a community-based nested case-control study
31 August 2025
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Webinar
LDL-C reduction postACS: strike early and strike strong
15 November 2021
thumbnail
Congress Presentation
GLP1-RA associated with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources